Virtu Financial’s Genocea Biosciences, Inc. GNCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-12,503
| Closed | -$15K | – | 2495 |
|
|
2021
Q4 | $15K | Buy |
+12,503
| New | +$15K | ﹤0.01% | 1552 |
|
|
2021
Q3 | – | Sell |
-15,625
| Closed | -$37K | – | 2362 |
|
|
2021
Q2 | $37K | Buy |
+15,625
| New | +$37K | ﹤0.01% | 1373 |
|
|
2020
Q3 | – | Sell |
-36,686
| Closed | -$84K | – | 1802 |
|
|
2020
Q2 | $84K | Buy |
+36,686
| New | +$84K | 0.01% | 925 |
|
|
2019
Q4 | $38K | Buy |
+18,460
| New | +$38K | ﹤0.01% | 1250 |
|
|
2019
Q3 | – | Sell |
-92,644
| Closed | -$363K | – | 2051 |
|
|
2019
Q2 | $363K | Buy |
+92,644
| New | +$363K | 0.02% | 673 |
|
|
2019
Q1 | – | Sell |
-7,152
| Closed | -$16K | – | 2103 |
|
|
2018
Q4 | $16K | Buy |
+7,152
| New | +$16K | ﹤0.01% | 1391 |
|
|
2018
Q2 | – | Sell |
-3,301
| Closed | -$28K | – | 2754 |
|
|
2018
Q1 | $28K | Sell |
3,301
-22,955
| -87% | -$195K | ﹤0.01% | 1792 |
|
|
2017
Q4 | $244K | Buy |
26,256
+893
| +4% | +$8.3K | 0.01% | 1461 |
|
|
2017
Q3 | $296K | Buy |
+25,363
| New | +$296K | 0.01% | 1397 |
|